Fennec Pharmaceuticals Inc. (FENC)
NASDAQ: FENC · Real-Time Price · USD
10.30
+0.77 (8.08%)
At close: Jun 23, 2026, 4:00 PM EDT
10.40
+0.10 (0.97%)
After-hours: Jun 23, 2026, 6:58 PM EDT

Fennec Pharmaceuticals Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
358263174296252114
Market Cap Growth
63.97%51.21%-41.18%17.26%120.37%-40.91%
Enterprise Value
317.61226.27166.68313.45253.3798.35
Last Close Price
10.307.706.3211.229.604.40
Forward PE
26.1915.88-90.85--
PS Ratio
7.025.893.6613.92164.33-
PB Ratio
9.447.42-29.63-25.45-98.197.26
P/TBV Ratio
8.366.20---7.26
P/FCF Ratio
--6.45---
P/OCF Ratio
--6.45---
EV/Sales Ratio
6.235.073.5114.75165.06-
EV/EBITDA Ratio
--64.91---
EV/EBIT Ratio
--64.91---
EV/FCF Ratio
--6.18---
Debt / Equity Ratio
-0-3.29-2.66-9.690.32
Debt / EBITDA Ratio
--7.53---
Debt / FCF Ratio
--0.72---
Net Debt / Equity Ratio
-1.07-1.041.24-1.52-0.44-1.02
Net Debt / EBITDA Ratio
6.645.86-2.84-1.38-0.050.94
Net Debt / FCF Ratio
6.962.95-0.27-1.03-0.061.13
Asset Turnover
0.720.771.320.790.060
Inventory Turnover
2.322.871.980.92-0.30-
Quick Ratio
6.155.715.712.925.4912.76
Current Ratio
6.986.376.383.565.8013.54
Return on Equity (ROE)
-23.88%-65.82%4.98%226.13%-359.22%-77.36%
Return on Assets (ROA)
-8.51%-11.00%43.92%-47.47%-91.54%-63.99%
Return on Invested Capital (ROIC)
-26.45%-36.15%178.13%-407.11%-18982.40%-127578.00%
Return on Capital Employed (ROCE)
-9.91%-12.81%8.96%-61.34%-104.85%-69.13%
FCF Yield
--15.51%---
Buyback Yield / Dilution
-10.35%-4.70%-2.71%-1.14%-1.03%-9.71%
Total Shareholder Return
-10.35%-4.70%-2.71%-1.14%-1.03%-9.71%
SEC Filings: 10-K · 10-Q